Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
COVID-19
100%
Randomized Clinical Trials
60%
Intensive Care Unit
49%
Intensive Care
40%
Cohort Analysis
40%
Prevalence
40%
Hospital Mortality
32%
Cohort Effect
32%
Odds Ratio
29%
Quality Improvement
24%
Hazard Ratio
24%
Perioperative Period
20%
Frailty
20%
Clinical Research
20%
Sepsis
20%
Home Rehabilitation
20%
Medical Science
20%
Angiotensin Receptor Antagonist
20%
Low and Middle Income Countries
20%
ACE Inhibitor
20%
Critical Illness
20%
Acute Disease
20%
Ascorbic Acid
20%
Oxygen Therapy
20%
Hypoxemia
20%
Artificial Respiration
16%
Case Mix
16%
Comorbidity
16%
Tracheostomy
15%
Physiotherapy
13%
Primary Outcome
12%
Hypertensive Factor
11%
Renal Replacement Therapy
11%
Charlson Comorbidity Index
8%
Noninvasive Ventilation
8%
Hospital Infection
8%
Health System
8%
Clinical Trial
8%
Medical Specialty
8%
Infection
8%
Enteric Feeding
6%
Health Care
6%
Catheter Care
6%
DNA Template
6%
Primary Health Care
6%
Checklist
6%
Emergency Care
6%
Nurse
6%
Nutrition
6%
Medical Research
6%
Nursing and Health Professions
COVID-19
60%
Prevalence
40%
Hazard Ratio
22%
Home Rehabilitation
20%
Peer Review
20%
Cohort Analysis
20%
Simvastatin
20%
Frailty
20%
Ascorbic Acid
20%
Hypoxemia
20%
Oxygen Therapy
20%
Odds Ratio
19%
Tracheostomy
13%
Physiotherapy
13%
Oxygenation
13%
Efficacy
12%
Intensive Care Unit
10%
Hospital Mortality
7%
Suction Catheter
6%
Catheter Care
6%
Home Care
6%
Mobile Application
6%
Primary Health Care
6%
Information Retrieval
6%
Health Care
6%
Emergency Care
6%
Health Care Facility
6%
Medical Device
6%
Enteric Feeding
6%
Hospital Infection
6%
Checklist
6%
House Call
6%
Titrimetry
6%
Artificial Respiration
6%
Hospital Discharge
5%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
60%
Infection
30%
Comorbidity
28%
Simvastatin
20%
Antiplatelet
20%
Dipeptidyl Carboxypeptidase Inhibitor
20%
Diseases
20%
Receptor Antagonist
20%
Interleukin 6
20%
Angiotensin Receptor Antagonist
20%
Coronavirinae
20%
Prevalence
20%
Hydroxychloroquine
20%
Lopinavir Plus Ritonavir
20%
Cohort Study
20%
Frailty
20%
Ascorbic Acid
20%
Hydrocortisone
10%
Antiviral Drug
10%
Antithrombocytic Agent
10%
Physical Disease by Body Function
6%
Virus Strain
6%
SARS Coronavirus
5%
Case Fatality Rate
5%
Clinical Feature
5%
